Advertisement

Topics

FDA approves Stimwave’s wireless neuromodulation device

01:57 EDT 10 Aug 2017 | Medical Business Review

Medical devices maker Stimwave has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its StimQ peripheral nerve stimulator (PNS) system.

Original Article: FDA approves Stimwave’s wireless neuromodulation device

NEXT ARTICLE

More From BioPortfolio on "FDA approves Stimwave’s wireless neuromodulation device"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...